Geoffrey W. Levin

Phone212 504 5550

Peer Rating

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials

Practice Areas

  • Corporate
  • Corporate Finance
  • Corporate Governance
  • Private Equity
  • Distressed Investing and Mergers & Acquisitions
  • Health Care
  • Mergers & Acquisitions
University University of Michigan, B.B.A., with high distinction, 1990
Law SchoolUniversity of Minnesota Law School, J.D., magna cum laude, 1993
Admitted1994, New York

Geoffrey Levin concentrates his practice on advising private equity sponsors and their portfolio companies on complex business transactions and governance matters. His representations span a variety of industries and disciplines, counseled clients on domestic and international mergers, acquisitions, leveraged buyouts, going private transactions, spin-offs, joint ventures, recapitalizations, venture capital/growth equity investments, restructurings and workouts, senior credit financings and mezzanine financings. He also has extensive experience as general partner counsel in the formation of domestic and international private equity funds.

Geoff's representations have covered a broad range of industries including life sciences, financial services, communications, energy, retail, automotive and heavy industrial.

Prior to joining Cadwalader, Geoffrey was a partner at Kirkland & Ellis and an associate at Cravath, Swaine & Moore. He authored the article Private Equity Club: Seller Beware? Latest Developments and Practice Tips, which appeared in the March-April 2007 edition of Deal Lawyers.

Geoffrey was recently named by IFLR 1000 as a leading M&A lawyer. He was also recognized by Institutional Investor News as one of the 10 Rising Stars of Private Equity and M&A Law, and by Mergermarkets as one of their 2009 Dealmakers of the Year.

Geoffrey received his J.D., magna cum laude and Order of the Coif, from the University of Minnesota, where he was executive editor of the Journal of International Economic Law & Policy, and a B.B.A., with high distinction, from the University of Michigan. He is admitted to practice in the State of New York.

ExperienceMergers & Acquisitions and Restructurings

• Vertis Holdings in its $363 million sale to Quad/Graphics.

• A medical device company in its sale to a strategic acquirer.

• Icahn Capital in its bid for Blockbuster, Inc.

• A biomass conversion start-up in equity financing.

• A consortium of hedge funds in a bid for over $6 billion in distressed real estate assets.

• CVC Capital Partners in its $4.4 billion agreement to acquire the iShares ETF business from Barclays.

• The U.S. Treasury in the Chrysler restructuring.

• CVC Capital Partners in its $2.3 billion take private acquisition of Univar N.V.

• Lyondell Chemical Company in the equity backstop by Apollo, Ares and Access Industries of a $2.8 billion rights offering.

• Hedge Fund in bid for eTrade Market Making business.

Preferred Stock/Venture Capital Investments

• A leading private equity firm with an exclusive focus on life sciences industries in multiple investments in domestic and multinational medical technology companies.

• Private investment fund in $30 million PIPE financing of biopharmaceutical company.

• Private investment fund in $75 million PIPE financing of National City Corporation.

• Management team in seed-capital funding arrangements for start-up.

• Investment fund in $100 million funding commitment and joint venture arrangements for start-up.

• ZS Fund in the acquisition of SOS Security

• Consortium of family office investors in bid for Lafarge Gypsum business

• Columbus Nora in a multi-tranche funding of a public company

Fund Formations

• CVC Capital Partners in raising over $20 billion of committed capital for their European and Asian Investment Funds.

• The general partners and limited partners in the formation of a wide variety of other country- or region-specific non-U.S. funds as well as sector funds.

News & Resources


News Releases

•Cadwalader Advising Salix Pharmaceuticals in its Combination with Cosmo Technologies to Form Salix Pharmaceuticals, plc
Jul 08, 2014

•Cadwalader Again Recognized Among Legal Leaders by IFLR 1000
Nov 15, 2013

•Cadwalader Recognized in 2013 Edition of The Legal 500 US
Oct 25, 2013

•IFLR 1000 Again Names Cadwalader a Leader in Core Transactional Areas of Practice
Nov 06, 2012

•IFLR 1000 Again Names Cadwalader a Leader in Core Transactional Areas of Practice
Oct 19, 2011

Recent Press

•Dealmaker in the Spotlight
Jun 01, 2009


•Cadwalader Again Recognized Among Legal Leaders by IFLR 1000
Nov 15, 2013

•Cadwalader Recognized in 2013 Edition of The Legal 500 US
Oct 25, 2013

•International Financial Law Review's 2013 IFLR 1000
Nov 06, 2012


Clients Friends Memos

•Time to Roll the Dice on Online Gaming?
Jan 12, 2012

•The Bribery Act 2010: Are You Ready?
Jun 30, 2011

•Del Monte Decision Enjoins Shareholder Vote and Deal Protections; Holds Buyer Potentially Responsible for Aiding and Abetting Seller Board's Fiduciary Breach
Feb 18, 2011


•Tainting The Sales Process
Mar 18, 2011


•A Discussion on Silicon Alley and New York Competitiveness
Jun 13, 2014



•Quorum: March 2014 V2N1
Mar 26, 2014

Profile Visibility
#10,001 in weekly profile views out of 89,481 lawyers in New York, New York
#118,117 in weekly profile views out of 1,538,052 total lawyers Overall

Office Information

Geoffrey W. Levin

New YorkNY 10281-0006


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now